Clinical trial
A Multicenter Study to Evaluate the Performance of Automated Retinal Disease Assessment Software for the Detection of More Than Mild Diabetic Retinopathy
NCT04905459 is registered in ClinicalTrials.gov with Verily Life Sciences LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Study to Evaluate the Performance of Automated Retinal Disease Assessment Software for the Detection of More Than Mild Diabetic Retinopathy
- Lead sponsor
- Verily Life Sciences LLC
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2021
- Completion date
- May 23, 2022
- Enrollment
- 1,012 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.